Іздеу

Шығарылым
Атауы
Авторлар
Cardiac toxicity of fluoropyrimidines in the treatment of solid gastrointestinal tumors
Bogatyreva L., Besova N., Yunayev G., Kurmukov I., Obarevich E., Gavrilova D., Egorova A., Lepkova N., Tryakin A.
New approaches to staging and treatment of primary endometrial cancer
Bakhidze E., Belyaeva A., Berlev I.
Prevalence of chronic kidney disease among cancer patients
Трофимцева Т., Yarovoy S., Gritskevich A.
Evaluation of long-term results of treatment of patients with residual tumors (including those with minimal forms of ypT1abN0), with pathomorphological complete response (pCR) after neoadjuvant systemic therapy, with primary minimal breast cancer (pT1abN0M0)
Pesotsky R., Semiglazov V., Krivorotko P., Tabagua T., Zernov K., Emelyanov A., Semiglazova T., Amirov N., Mortada V., Ulrikh D., Levchenko V., Rychagov K., Zirov K., Evseev V.
Lorlatinib in the treatment of ALK-positive non-small cell lung cancer
Gordeeva O., Meshcheryakova N., Meshcheryakov A.
PARP inhibitors in a personalized approach to the treatment of castration-resistant prostate cancer: clinical case
Gritskevich A., Byteman T., Monakov D., Rusakov I., Mishugin S.
The role of cyclin-dependent kinase inhibitors in adjuvant therapy of breast cancer
Semiglazov V., Krivorotko P., Bekkeldiyeva N., Komyakhov A., Emelyanov A., Gorina A.
Reconstructive plastic surgery of the breast using autogenous tissue. Historical aspects
Khakimova S., Zikiryakhodzhaev A., Kaprin A., Khakimova G., Onofriychuk I., Rasskazova E., Sukhotko A., Vlasova M., Bosieva A., Tokaev V.
Pelvic extrusion in patients with cervical cancer: clinical experience
Khakimov G., Khakimova G., Musurmonov K., Khakimova S., Orifjonova G.
Treatment of locally advanced (T2-3N0-1M0) and early (T1-2N0M0) HER2-positive breast cancer (clinical experience)
Semiglazov V., Komyakhov A., Yerechshenko S., Tabagua T., Gigolaeva L., Tseluyko A., Tergoeva A., Kazantseva M., Amirov N., Mortada V., Pesotsky R., Enaldieva D., Shaihelislamova L., Nikolaev K., Zhiltsova E., Krivorotko P.
Analysis of the effectiveness of various neoadjuvant chemotherapy regimens in patients with T1-3N1-3M0 I–IIIC stage locally advanced breast cancer
Pesotsky R., Semiglazov V., Krivorotko P., Tabagua T., Zernov K., Emelyanov A., Yerechshenko S., Amirov N., Mortada V., Ulrikh D., Levchenko V., Rychagov K., Zirov K., Evseev V.
Primary resistance to anti-HER2 therapy: mechanisms of development and ways to overcome
Dashyan G., Dzhelialov E., Konstantinova V., Gronskaya Y., Murskikh A., Akhmedov R., Tyusenko A., Olchonova A., Dyakonenko Z., Sereda O., Belousov A.
Venous thrombosis and malignant gynecological diseases: the place of direct oral anticoagulants in prevention
Ulrikh E.
Clinical efficacy of multi-dose vaccination against human papillomavirus infection in the Moscow region
Belaya Y., Zarochentseva N.
Conversion therapy for stage IV gastric cancer: a review of prognostic factors and patient selection criteria according to the literature data
Besova N.
Combination of sarcoidosis and sigmoid colon cancer: a clinical observation
Dmitrieva N., Mavlyavieva E., Chernikova Y., Fedotov E., Mirilashvili T.
Data in the treatment of colon cancer from real clinical practice in Tashkent, Uzbekistan
Khakimova G., Tryakin A.
Possibilities of overcoming hormone resistance in patients with metastatic HR+ HER2- breast cancer using the drug alpelisib in various subgroups in real clinical practice
Orlova R., Gluzman M., Vakhitova A.
Clinical experience with the use of combination drug therapy in the first line treatment of metastatic non-small cell lung cancer
Ivanova F., Nikolaeva T., Spiridonova N., Afanasyeva L., Nikiforov P., Zharnikova T.
GSTT1 and GSTM1 deletion polymorphism as a predictor of response to hormonal therapy for breast cancer
Gulian I., Bystritskaya E., Otstavnykh N., Khudchenko E., Eliseeva E., Apanasevich V., Isaeva M.
Prospective randomized phase III trial comparing FOLFIRINOX and mFOLFOX6 as first-line treatment for patients with disseminated gastric cancer: interim assessment of tolerability and toxicity
Gavrilova D., Besova N., Obarevich E., Makiev G., Tryakin A., Stilidi I.
TIME COURSE AND PROGNOSIS OF BENIGN AND MALIGNANT TUMORS OF THE FEMALE REPRODUCTIVE SYSTEM ON THE BACKGROUND OF COMORBID CONDITIONS
Vertkin A., Kozlova O., Khashukoeva A., Vertkin A., pl?midmagidsid h., Khashukoyeva A.
Trastuzumab deruxtecan in the treatment of breast cancer
Semiglazov V., Krivorotko P., Bekkeldieva N., Gorina A., Komyakhov A., Paltuev R., Tabagua T., Ereshenko S.
Safety of continuous glycemic monitoring system in patients after total duodenopancreatectomy in the early postoperative period. Single-center retrospective cohort study
Farmanov A., Bublik E., Vinogradskaya O., Udovichenko O., Zilov A., Ryzhkova E., Egorov V., Fadeev V., Deunezheva S., Zhivov A., Tobianskaya I.
Ceritinib in the treatment of ALK-positive non-small cell lung cancer
Gordeeva O., Ivanova K., Meshcheryakov A.
Delay of initiation of adjuvant chemotherapy in patients with early breast cancer: causes and consequences
Dashyan G., Konstantinova V., Dzhelialov E., Akhmedov R., Semiletova Y., Zhurov A., Tyusenko A., Olchonova A., Pavlikova I., Belousov A.
Possibilities of vitamin-mineral complexes in adjuvant therapy of thyroid diseases
Trukhan D., Viktorova I., Druk I.
Conversion therapy for disseminated gastric cancer. Interim results of a retrospective analysis of our own data
Besova N., Obarevich E., Tryakin A., Gavrilova D., Nered S., Kalinin A., Stilidi I.
Neoadjuvant and postneoadjuvant treatment for triple negative breast cancer
Semiglazov V., Dzhelyalova M., Tseluyko A., Pesotsky R., Bessonov A., Semiglazova T.
Novye vozmozhnosti ispol'zovaniya targetnoy terapii v lechenii nekotorykh solidnykh opukholey (po materialam ESMO-2014)
Dobrova N.
CAPECITABINE AND FLUOROURACIL IN THE TREATMENT OF COLORECTAL CANCER AND GASTRIC CANCER: ANALYSIS OF DIRECT COMPARATIVE STUDIES
Fedyanin M., Tryakin A., Fedyanin M., Tryakin A.
Non-small lung cancer. Expanding therapeutic opportunities: pembrolizumab in a number of malignant tumors
Gutorov S., Borisova E., Abramov M., Lud A., Arutyunyan E.
Klinicheskiy sluchay uspeshnogo lecheniya erilibulinom metastaticheskogo raka molochnoy zhelezy
Limareva S., Laytsan K., Stroyakovskiy D., Demidova I., Gorbunova V.
The role of alpelisib in the treatment of PIK3CA - a mutated breast cancer
Semiglazov V., Krivorotko P., Komyakhov A., Semiglazova T., Gigolaeva L., Tabagua T., Kazantseva M., Tergoeva A., Ulrikh D., Chervyak M., Klimenko V., Amirov N., Zhiltsova E., Semiglazov V.
The effect of drug therapy and cetuximab on the mutational status of the KRAS gene in patients with squamous cell carcinoma of the tongue and oral floor mucosa
Lyanova A., Vladimirova L., Kutilin D., Abramova N., Popova I., Tikhanovskaya N., Teplyakova M., Novoselova K., Myagkova V., Alieva F., Ryadinskaya L.
Experience of the use of ixabepilone in polychemotherapy regimens for disseminated triple-negative breast cancer
Glazkova E., Frolova M., Menshikov S., Stenina M.
Perspektivy primeneniya kapsul vinorelbina v sovremennoy onkologii
Gutorov S., Stepanchenko M., Lichinitser M.
Eribulin – novyy mikrotrubochkovyy ingibitor dlya lecheniya metastaticheskogo raka molochnoy zhelezy
Stenina M.
Opyt kombinirovannogo lecheniya bol'nykh kolorektal'nym rakom s izolirovannymi metastazami v pecheni
Chernoglazova E., Vyshinskaya G., Sagaydak I., Rotobel'skaya L., Vorontsova K.
Modern approaches to the treatment of muscle-invasive bladder cancer
He Mingze -., Zeng Zitong -.
Rol' aflibertsepta v lechenii metastaticheskogo kolorektal'nogo raka
Meshcheryakov A.
Rol' gistologicheskogo i molekulyarnogo analiza v vybore metoda lecheniya nemelkokletochnogo raka legkogo pozdnikh stadiy
Vladimirova L., Kit O., Sholokhova E.
Abemacyclib is a unique representative of the class of CDK4/6 inhibitors in the treatment of HR+/HER2- metastatic breast cancer
Grechukhina K., Vorontsova K., Kuko T., Prosvirnov A., Ganshina I., Lubennikova E., Kolyadina I., Zhukova L.
TREATMENT OF NON-SMALL CELL LUNG CANCER: THE NEXT STEP
Borisova E., Gutorov S., Abramov M.
Osobennosti klinicheskogo techeniya invazivnogo dol'kovogo raka molochnoy zhelezy
Borisova E., Vyshinskaya G., Gutorov S., Stepanchenko M.
Avastin (bevacizumab) in the treatment of tumors of the stomach and pancreas
Semenov N.
Clinical significance of genetic polymorphism of tamoxifen metabolic enzymes and transporters in breast cancer: results of a population-based cohort study
Golubenko E., Savelyeva M., Sozaeva Z., Poddubnaya I., Korennaya V.
Clinical immunology of breast cancer
Tseluiko A., Semiglazov V., Kudaibergenova A., Artemyeva A., Paltuev R., Donskikh R., Pesotsky R., Krivorotko P.
Neoadjuvant immunotherapy for non-small cell lung cancer
Semenova A., Protsenko S., Teletaeva G., Latipova D., Novik A.
Optimization of the tactics of adjuvant chemotherapy in patients with colon cancer taking into account clinical and morphological characteristics
Ivanova A., Orlova R., Raskin G., Kutukova S.
Rare case of pheochromocytoma with calcitonin hypersecretion
Rebrova D., Rusakov V., Fedorov E., Krasnov L., Vorokhobina N., Shikhmagomedov S., Vorobyev S., Sleptsov I., Chernikov R., Savelyeva T., Semenov A., Chinchuk I., Sablin I., Pridvizhkina T., Fedotov Y.
Optimal treatment strategy for a patient with advanced ovarian cancer without deterioration in the quality of life: a clinical case
Khokhlova S.
Influence of FOLFIRINOX on the achievement of resistability in patients with rectal and liver metastases
Khakimov G., Dzhumaniezov K., Kadyrov S., Khakimova G., Abdulkhuseynova S., Poluzhkina I.
Intermediate assessment of the results of a clinical study of a neoadjuvant combined treatment of patients with high-risk and very high-risk prostate cancer
Buevich N., Protsenko S., Nosov A., Reva S., Artemyeva A., Berkut M.
Current aspects of the treatment of BRCA-associated ovarian cancer
Rumyantsev A.
INTERCELLULAR ADHESION MOLECULES (E-CADHERIN, ß-CATENIN) IN COLORECTAL CANCER: CHARACTERISTICS; ROLE IN MECHANISMS OF TUMOR INVASION, METASTASIS AND REGULATION OF TUMOR PROGRESSION; INFLUENCE ON PROGNOSIS (LITERATURE REVIEW)
Darenskay A., Dobrova N., Stepanova E.
Skin melanoma in practice of dermatologist
Sergeev Y., Mordovtseva V., Sergeev V.
Ixempra - new possibilities of cytostatic therapy of breast cancer
Lubennikova E., Zhukova L., Arutyunyan E.
Cashuistic case of treatment of discemned small-cell lung cancer
Khakimova G., Titova T., Kuzminov A., Gorbunova V., Delektorskaya V., Borisova T.
METASTATIC GASTRIC CANCER: DESCRIPTION OF CLINICAL CASE
Abramov M., Bardovskaya K., Mescheryakov A., Medvedeva B.
FIRST-LINE ENDOCRINE THERAPY OF HORMONE RECEPTOR-POSITIVE HER2-NEGATIVE METASTATIC BREAST CANCER. TIME OF CHANGE AFTER A LONG-TERM CALM PERIOD
Zhukova L., Manikhas A.
TARGETED THERAPY IN COMPLEX TREATMENT OF RENAL CANCER PATIENTS WITH BRAIN METASTASES
Naskhletashvili D.
Sovremennye vozmozhnosti lecheniya bol'nykh disseminirovannym kolorektal'nym rakom: II liniya lekarstvennoy terapii -
Vorontsova K., Dobrova N., Vyshinskaya G.
Issledovanie faktorov rosta pri razlichnykh zabolevaniyakh predstatel'noy zhelezy
Kostin A., Andryukhin M., Pul'bere S., Motin P., Agaev N.
Opyt lecheniya bol'nykh metastazami kolorektal'nogo raka: irinotekan+raltitreksed (2-ya liniya khimioterapii)
Vorontsova K., Dobrova N., Vakhabova Y., Vyshinskaya G.
ALK-POZITIVNYY NEMELKOKLETOChNYY RAK LEGKOGO: NOVYE PATsIENTY I NOVYE VOZMOZhNOSTI LEKARSTVENNOGO LEChENIYa
Breder V., Laktionov K.
Gormonoterapiya metatstaticheskogo i retsidivnogo raka endometriya
Bakhidze E.
NOVYE VOZMOZhNOSTI TERAPII BOL'NYKh METASTATIChESKIM RAKOM MOLOChNOY ZhELEZY, POLUChAVShIKh RANEE ANTRATsIKLINI TAKSAN-SODERZhAShchUYu KhIMIOTERAPIYu: OBZOR LITERATURY I KLINIChESKIY SLUChAY
Zhukova L.
Hormonal treatment of breast cancer: optimal sequence and issues of overcoming the resistance
Borisova E., Gutorov S., Vorontsov A.
Current potentials for the drug therapy of adrenocortical cancer
Filimonyuk A.
VEDENIE PATsIENTOV S KhRONIChESKIMI VIRUSNYMI GEPATITAMI I ONKOLOGIChESKOY PATOLOGIEY
Bogomolov P., Bueverov A., Matsievich M., Voronkova N., Kokina K., Koblov S., Trofimova M.
CLINICAL EXPERIENCE OF USE OF BEVACIZUMAB (AVASTIN) IN PATIENTS WITH METASTATIC BREAST CANCER WITH UNIDENTIFIED HER2/NEW AND ER PR-RECEPTOR STATUS
Konstantinova M., Shikina V., Makshantsev A., Konstantinova M., Shikina V., Makshantsev A.
DRUG ZOMETA IN ADDITION TO THE CHEMOTHERAPY SIGNIFICANTLY INCREASES OVERALL SURVIVAL IN PREVIOUSLY UNTREATED PATIENTS WITH MULTIPLE MYELOMA
Zhukov N., Zhukov N.
EPIDEMIOLOGY, DIAGNOSIS AND TREATMENT OF CRYPTORCHIDISM UNDER PRESENT-DAY CONDITIONS
Hamidov S., Ovchinnikov R., Myasnikov D., Pavlovichev A., Tazhetdinov O., Tkhagapsoeva R., Gamidov S., Ovchinnikov R., Myasnikov D., Pavlovichev A., Tazhetdinov O., Tkhagapsoeva R.
Ixabepilone in the treatment of breast cancer
Semiglazov V., Krivorotko P., Semiglazova T., Komyakhov A., Tabagua T., Kazantseva M., Zhiltsova E., Ulrikh D., Chervyak M., Tergoeva A., Klimenko V., Semiglazov V.
Diagnosis of HPV-associated cervical diseases in postmenopausal women. Problems and solutions
Dovletkhanova E.
Systemic alpha-radiotherapy with radium-223 (Xofigo) in patients with metastatic castration-resistant prostate cancer (mCRPC). Clinical experience of using the drug in Sverdlovsk Regional Oncological Dispensary, Yekaterinburg
Kulakova A., Bentsion D., Elishev V., Vetrov V.
Sentinel lymph node scintigraphy in breast cancer. Own experience
Afanasyeva N., Vazhenin A., Trofimchuk L., Chvanova K.
A unique case of colon cancer metastasis treatment. A case from practice
Khakimova G., Islamov F., Khakimov G.
Abemacyclib - new options for the treatment of hormone-positive metastatic breast cancer with CDK4/6 inhibitors
Semiglazova T., Volynshchikova O., Semiglazov V., Klimenko V., Brish N., Alekseeva Y., Klyuge V., Krutov A., Paltuev R., Kasparov B., Krivorotko P., Semiglazov V.
Primary multiple colonic tumors of various genetic characteristics in a patient with familial adenomatous polyposis: description of the clinical case
Gutorov S., Borisova E., Ivanova K., Manukyan M., Abdulkhuseinova S.
A prospective non-randomized trial: the use of platinum-containing chemotherapy with mitomycin for relapses of BRCA1-associated ovarian cancer
Kotiv K., Yakovleva M., Sokolenko A., Gorodnova T., Ivantsov A., Nekrasova E., Smirnova O., Sidoruk A., Bondarev N., Meshkova I., Mikaya N., Petrik S., Urmancheeva A., Ulrikh E., Protsenko S., Belyaev A., Imyanitov E., Berlev I.
Prognostic and predictive values of the PIK3CA gene mutation in patients with breast cancer
Semiglazova T., Sorokina I.
RAMUCIRUMAB IN A COMBINATION WITH IRINOTECAN-BASED TWO-COMPONENT THERAPY REGIMEN AS THE SECOND LINE FOR THE TREATMENT OF DISSEMINATED GASTRIC CANCER. CASE REPORT
Titova T., Besova N., Gorbunova V., Fedenko A., Malikhova O.
GONADOTROPIN-RELEASING HORMONE AGONISTS-INDUCED OVARIAN SUPPRESSION IN EARLY BREAST CANCER
Semiglazova T., Berlev I., Ulrikh E., Semiglazov V., Protasova A., Brish N., Korobeynikova E., Alekseeva Y., Filatova L., Semenova A., Latipova D., Teletaeva G., Tkachenko E., Klimenko V., Dashyan G., Protsenko S., Paltuev R., Urmancheeva A., Krivorotko P., Semiglazov V.
Prognostic values of the presence of disseminated tumor cells in the bone marrow in patients with disseminated stomach cancer before start of treatment with antitumor drugs
Besova N., Obarevich E., Davydov M., Beznos O., Tupitsyn N.
ONCOMODULATING EFFECT OF CYTOMEGALOVIRUS IN BLADDER CANCER: MYTH OR REALITY?
Loran O., Sinyakova L., Gundorova L., Kosov V., Kosova I., Pogodina I., Kolbasov D.
WHETHER PRIMARY TUMOR LOCALIZATION IS IMPORTANT FOR THE PREDICTION OF DRUG TREATMENT OF METASTATIC COLON CANCER?
Dobrova N., Borisova E., Gutorov S., Abramov M.
ROLE OF NEW ANTIANGIOGENIC DRUGS IN THE SECOND-LINE TREATMENT OF NON-SMALL-CELL LUNG CANCER
Semenova A., Protsenko S., Novik A., Latipova D., Teletayeva G., Semiglazova T.
MODERN POSSIBILITIES OF MEDICAL TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC BLADDER CANCER
Vorontsova K., Zhukova L.
Struktura slizistoy obolochki zheludka u bol'nykh rakom zheludka v Respublike Khakasiya
Tsukanov V., Kasparov E., Butorin N., Shtygasheva O., Vasyutin A., Amel'chugova O., Tonkikh Y., Bronnikova E.
KOMPLEKSNAYa TERAPIYa HER2-POZITIVNOGO RAKA MOLOChNOY ZhELEZY
Semiglazov V., Semiglazov V., Nikolaev K., Dashyan G., Paltuev R.
Novye metody terapii v lechenii kastratsionnorezistentnogo raka predstatel'noy zhelezy
Sokov D.
SOVREMENNYE PODKhODY K LEKARSTVENNOY TERAPII BOL'NYKh METASTATIChESKIM KASTRATsIONNO-REFRAKTERNYM RAKOM PREDSTATEL'NOY ZhELEZY
Kaprin A., Alekseev B., Nyushko K., Kalpinskiy A.
Znachenie molekulyarnykh markerov pri vybore neoad\"yuvantnoy khimioterapii mestno-rasprostranennogo raka molochnoy zhelezy
Semiglazova T., Semiglazov V., Filatova L., Krivorot'ko P., Klimenko V., Ivanov V., Novikov S., Gershanovich M., Imyanitov E., Semiglazov V.
NASTOYaShchEE I BUDUShchEE TARGETNOY TERAPII V PERVOY LINII LEChENIYa RAKA YaIChNIKOV
Tyulyandina A.
A new approach to the overcoming resistance to hormone therapy of breast cancer
Semiglazova T., Semiglazov V., Filatova L., Krivorot'ko P., Klimenko V., Gershanovich M., Semiglazov V.
Khronicheskiy gastrit: kak preodolet' kompleks neopredelennosti?
Khomeriki N., Khomeriki S.
SKRININGOVOE OBSLEDOVANIE BOL'NYKh S KhRONIChESKIMI ZABOLEVANIYaMI PEChENI DLYa VYYaVLENIYa RANNIKh STADIY GEPATOTsELLYuLYaRNOGO RAKA
Zinatulin D., Trandofilov M., Shevchenko V., Vedeneev A.
TARGETED THERAPY AFTER PROGRESSION OF HER-2-POSITIVE BREAST CANCER
Tat'yana Y., Semiglazov V., Larisa V., Chubenko V., Nikita V., Fedor V., Latipova D., Mikhail L., Semiglazova T., Semiglazov V., Filatova L., Chubenko V., Brejnev N., Moiseenko F., Latipova D., Gershanovich M.
Нәтижелер 273 - 1/100 1 2 3 > >> 
Сыбырсөздер:
  • Негізгі сөздер тіркелімге сезімтал< / li>
  • Ағылшын предлогтары мен одақтары еленбейді
  • Әдепкі бойынша іздеу барлық негізгі сөздер үшін жасалады (агенс AND экспериенцер)
  • Белгілі бір терминді табу үшін OR қолданыңыз. білім беру OR оқыту
  • мысалы, күрделі сөз тіркестерін жасау үшін жақшаларды қолданыңыз. мұрағат ((журналдар OR конференциялар) NOT диссертациялар)
  • Нақты фразаны табу үшін, мысалы, тырнақшаларды қолданыңыз. "ғылыми зерттеулер"
  • сөзді - (сызықша) немесе not операторының көмегімен алып тастаңыз; мысалы. сұлулық байқауы< / em > немесе сұлулық байқауы< / em > < / li>
  • мысалы, нұсқа ретінде * қолданыңыз. ғылым* "ғылыми","ғылыми"және т. б. сөздерді қамтиды< / li> < / < / к-сі>

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>